Wealth Effects LLC Sells 299 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Wealth Effects LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,097 shares of the healthcare conglomerate’s stock after selling 299 shares during the period. UnitedHealth Group makes up about 0.9% of Wealth Effects LLC’s portfolio, making the stock its 23rd largest position. Wealth Effects LLC’s holdings in UnitedHealth Group were worth $2,146,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. Finally, Promus Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently commented on the stock. Bank of America downgraded shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their target price for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $405.00 to $418.00 and gave the company an “overweight” rating in a research report on Friday, June 20th. Truist Financial restated a “buy” rating and set a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. UBS Group decreased their price objective on shares of UnitedHealth Group from $400.00 to $385.00 and set a “buy” rating for the company in a report on Wednesday. Finally, Wolfe Research decreased their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a report on Tuesday, May 20th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $415.57.

UnitedHealth Group Price Performance

UNH stock opened at $302.19 on Thursday. The firm has a 50 day moving average of $342.22 and a 200-day moving average of $458.07. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a market capitalization of $274.13 billion, a P/E ratio of 12.65, a price-to-earnings-growth ratio of 1.45 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter last year, the business posted $6.91 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.93%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group’s payout ratio is presently 37.02%.

Insider Transactions at UnitedHealth Group

In related news, CEO Stephen J. Hemsley bought 86,700 shares of the company’s stock in a transaction dated Friday, May 16th. The stock was purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the acquisition, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director John H. Noseworthy purchased 300 shares of the firm’s stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the purchase, the director now directly owns 6,063 shares in the company, valued at $1,892,626.08. The trade was a 5.21% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.